D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years

Authors: Turkova, Anna, Chan, Man K., Kityo, Cissy, Kekitiinwa, Adeodata R., Musoke, Philippa, Violari, Avy, Variava, Ebrahim, Archary, Moherndran, Cressey, Tim R., Chalermpantmetagul, Suwalai, Sawasdichai, Kanokkorn, Ounchanum, Pradthana, Kanjanavanit, Suparat, Srirojana, Sakulrat, Srirompotong, Ussanee, Welch, Steven, Bamford, Alasdair, Epalza, Cristina, Fortuny, Clàudia, Colbers, Angela, Nastouli, Eleni, Walker, Simon, Carr, Dan, Conway, Magda, Spyer, Moira J., Parkar, Nazia, White, Iona, Nardone, Alessandra, Thomason, Margaret J., Ferrand, Rashida A., Giaquinto, Carlo, Ford, Deborah

Source: In Contemporary Clinical Trials July 2024 142